Cytochrome P450 enzymes as target for drug development
shown them to be bioactivated by CYP1A1 and 2W1 in cell-free and cell-based assays. At the meeting we will update on novel data from our drug discovery programme
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
shown them to be bioactivated by CYP1A1 and 2W1 in cell-free and cell-based assays. At the meeting we will update on novel data from our drug discovery programme
protocol in order to obtain nanotherapies that are safe for use in patients. Cell-based assays are the most commonly used approach for nanotoxicity assessment, but these methods are known
vivo and ultimately to human studies: mostly of promising molecules in cell-based assays fail in phase II and phase III. This passage from impressive in vitro activity to less
process such as in-silico screening, co-crystal structure determination, binding study and cell-based assay of the BRD2-BD2 complex will be discussed
CD40-TRAF6 interaction and combined in silico researches with in vitro cell-based assays and biophysical methods. Top hit molecules were administered to Apoe-/- mice models of initial
selectively affect -secretase cleavage of APP while sparing Notch cleavage, we generated cell-based assays employing Bioluminescence Resonance Energy Transfer (BRET) technology to monitor the protein-protein…
detected in serum by various assays like western blot, indirect immunofluorescence (IIF) -Cell-based assay and enzyme-linked immunosorbent assay (ELISA). Each method has its own advantages and limitations. ELISA
ricin loop (SRL) of the 28S rRNA, an activity measurable in in vitro translation assays. The SRL, one of the longest conserved stretches of rRNA sequence, makes direct interactions with ... biodistribution have severely…
assay. The active compounds have also been tested on HIV-1 replication in cell-based assays. Findings: Five of the isolated compounds inhibited IN activity with IC50 values
assays. The signaling pathways were also investigated by Western blotting and all the cell-based assays were used with or without pharmacological inhibitors of mitogen-activated protein kinase (MAPK)…
evaluated via flow cytometry and ELISA assay. Results: Nanoparticles demonstrated sustained Amy-F release properties and apparent selectivity towards BC cells. Cell-based assays revealed that Amy-F markedly suppresses
ligand binding affinity, selectivity, and agonist or antagonist activity at opioid receptors [8]. Cell-based assays, including calcium mobilization assays and cAMP accumulation assays, provide insights into…
extracts of natural products impact assay performance leading to high rate of false-positives and/or false-negatives. The use of cell-based ... assys overcomes many of the shortcomings of HTS with natural products…
assay with IC50 of 216 nM. To delineate the underlying mechanism of IRAK4 target-based inhibition of lymphoma proliferation, in this study, this compound was further evaluated in cell-based
EDCs using mammalian cell lines expressing GFP-tagged nuclear steroid receptor constructs. This assay is based on translocation of a fluorescent marker from the cytoplasm to the nucleus ... presence of the hormone or…
need for good bioassays to create potency, stability and neutralizing antibody (NAb) assays. Ideal bioassays need to reflect the clinical mechanism of action (MOA) of the biopharmaceutical drug and should…
novel isolates obtained were pharmacologically screened for activity in a variety of cell-based and pure enzyme assays designed to identify promising lead compounds for the development of drugs
selection of mammalian cells for applications in regenerative medicine as well as cell-based functional assays or drug screening protocols. Interestingly, also was discovered that multiple steps of ultra-quick…
MASTL kinase inhibitors using in vitro kinase assay in the present study. These compounds will be less toxic to the normal cells. The development of new anticncer drugs has been ... cells were used to evaluate the…
drugs. This may lead to significantly different concentrations between biosimilar and innovator drug. Cell-based potency assays may not be able to detect differences between biosimilar and innovator
system, GNE has been shown to affect cell adhesion property via hyposialylation of β-1 integrin. This leads to increased binding of cell to fibronectin and activation ... base for understanding pathomechanism of GNE…
opportunity for developing anti-HIV-1 drugs. Method: In this study, a cell-based ELISA assay was used to screen for small molecule compounds that restore cell surface
study, we measured the antioxidant activity of major CGA isomers using chemical and cell-based antioxidant assays. Furthermore, we explored the relationship between the antioxidant activity capacity with affinity
The enzymes of the methylerythritol phosphate (MEP) pathway are important drug targets
synergy in several mixtures to quench the DPPH radical and in the DCF cell-based antioxidant assay. We also performed an interaction analysis of the combination of polyphenols present
For authors and organisers
Find the right journal for your paper and submit your manuscript.